Thyroid autograft: A twelve-year follow up

Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy

“…Thyroid disease, with clinical manifes-ATPO titers ¢18 IU/mL. IFN-a treatment significantly intations of hypothyroidism or hyperthyroidism, has been recreased overall thyroid dysfunction (9.7%; P Å .001) andported in 5% to 12% of patients who received IFN-a for hypothyroidism (7.8%; P Å .01), particularly among patients various diseases, [9][10][11] while antithyroid autoantibodies were with high baseline ATPO (38.5%; P Å .0002). Six months present in a high percentage.…”

“…Six months present in a high percentage. [11][12][13][14] Indeed, only a minority of after stopping IFN-a treatment, the prevalence of thyroid dyspatients with chronic viral hepatitis who are positive for function was 8.0%, still significantly higher than at baseline.antimicrosomal or antithyroid antibodies have thyroid dys-By multivariate analysis, the only predictor positively associfunction, which is usually subclinical. 4 However, such paated with pre-or on-treatment hypothyroidism was the basetients may be at a particularly high risk for the development line titer of the ATPO antibodies (relative risk [RR], 3.0 and of thyroid disease when treated with IFN-a.…”

“…ported in 5% to 12% of patients who received IFN-a for hypothyroidism (7.8%; P Å .01), particularly among patients various diseases, [9][10][11] while antithyroid autoantibodies were with high baseline ATPO (38.5%; P Å .0002). Six months present in a high percentage.…”

“…Six months present in a high percentage. [11][12][13][14] Indeed, only a minority of after stopping IFN-a treatment, the prevalence of thyroid dyspatients with chronic viral hepatitis who are positive for function was 8.0%, still significantly higher than at baseline.…”

“…Six months present in a high percentage. [11][12][13][14] Indeed, only a minority of after stopping IFN-a treatment, the prevalence of thyroid dyspatients with chronic viral hepatitis who are positive for function was 8.0%, still significantly higher than at baseline. antimicrosomal or antithyroid antibodies have thyroid dys-By multivariate analysis, the only predictor positively associfunction, which is usually subclinical.…”